Showing results (2261-2270 of 6,777) with videos related to

Sort By:
Pageof 678
Clinical Therapeutics|September 18, 2001
Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patientsP F Smith, C H Ballow, B M Booker, et al.
Clinical Therapeutics|January 30, 2002
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trialH B DuBiner, M Mroz, A M Shapiro, et al.
Clinical Therapeutics|January 30, 2002
Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspectiveB J O'Brien, R Goeree, L Bernard, et al.
Clinical Therapeutics|January 29, 2021
Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung CancerJiao Wu, Aifen Zhang, Lu Li, et al.
Clinical Therapeutics|January 1, 1988
Cost-effectiveness of including cromolyn sodium in the treatment program for asthma: a retrospective, record-based studyR N Ross, M Morris, S R Sakowitz, et al.
Clinical Therapeutics|January 1, 1988
Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitusJ Waysbort, G Regitz, D Brunner
Clinical Therapeutics|September 29, 2019
Cost-effectiveness Analysis of Empagliflozin in Japan Based on Results From the Asian subpopulation in the EMPA-REG OUTCOME TrialKohei Kaku, Masakazu Haneda, Hiroyuki Sakamaki, et al.
Clinical Therapeutics|September 30, 2019
Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic AsthmaAbhishek Kavati, Maryia Zhdanava, Benjamin Ortiz, et al.
Clinical Therapeutics|August 25, 2019
Assessing Biopharmaceutical Company Experience with Patient-centric InitiativesDebra L Michaels, Mary Jo Lamberti, Yaritza Peña, et al.
Clinical Therapeutics|August 26, 2019
Efficacy and Tolerability of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Neurologic DiseasesYun Chen, Chunyu Wang, Fanxi Xu, et al.
Pageof 678